(Q30411052)

21 June 2017

title

Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry (English)

1 reference

21 June 2017

Tracie L Williams

1

1 reference

21 June 2017

James L Pirkle

series ordinal

2

1 reference

21 June 2017

John R Barr

series ordinal

3

1 reference

21 June 2017

language of work or name

English

0 references

publication date

22 December 2011

1 reference

21 June 2017

1 reference

21 June 2017

volume

30

1 reference

21 June 2017

issue

14

1 reference

21 June 2017

page(s)

2475-2482

1 reference

Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Influenza pandemic planning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Optimization of digestion parameters for protein quantification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Inactivation of DNA by beta-propiolactone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Amino acid analysis of peptides using isobaric-tagged isotope dilution LC-MS/MS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Evolution of seed allergen quantification--from antibodies to mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Sequencing of oxidized methionine-containing peptides for protein identification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Oxidative post-translational modification of tryptophan residues in cardiac mitochondrial proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

LC/MS characterization of undesired products formed during iodoacetamide derivatization of sulfhydryl groups of peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Sample preparation for peptide mapping--A pharmaceutical quality-control perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Targeted N-linked glycosylation analysis of H5N1 influenza hemagglutinin by selective sample preparation and liquid chromatography/tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

Database resources of the National Center for Biotechnology Information

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.056

10.1016/J.VACCINE.2011.12.056

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference